NKCFO LLC’s Labcorp LH Stock Holding History

NKCFO LLC’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,979	Closed	-$434K	–	141
2021 Q1	$434K	Buy	+1,979	New	+$397K	0.16%	38

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NKCFO LLC's LH Position: Q2 2021 in Review

NKCFO LLC sold out of Labcorp (LH) in Q2 2021, closing a stake of 1,979 shares — an estimated $434K sold.

NKCFO LLC first reported a position in LH in Q1 2021 and held it in 1 quarter. The position peaked at $434K in Q1 2021. 948 funds tracked by Wall St. Rank hold LH as of Q2 2021.

NKCFO LLC reported no remaining Labcorp position as of Q2 2021 after selling out during the quarter.
NKCFO LLC sold 1,979 Labcorp shares in Q2 2021, an estimated $434K.
NKCFO LLC first reported a position in Labcorp in Q1 2021 and held it in 1 quarter.
NKCFO LLC's Labcorp position peaked at $434K in Q1 2021.
948 funds tracked by Wall St. Rank held Labcorp as of Q2 2021.

Based on NKCFO LLC's 13F filing for Q2 2021, filed 22 Jul 2021.